SURGICAL
hamburger
product photo

THE ORIGINAL OPHTHALMIC VISCOELASTIC DEVICE 

With 35 years in the industry, the HEALON® Ophthalmic Viscoelastic Device (OVD) represents a standard in reliability.

HIGHLY RELIABLE

Because of its high viscosity, the HEALON® OVD offers both excellent space creation and endothelial cell protection.1

  • Maintains a deep anterior chamber1
  • Allows easy maneuverability2
  • Aids in IOL implantation2

EASY TO USE

The HEALON® OVD is both easy to inject and easy to remove,1,2 helping provide simple manipulation in the eye2 with minimal workflow disruption. Formulated with outstanding clarity,1,2 it provides an unobstructed view of the surgical field.

HEALON® OVD

Classification

Cohesive

Product Volume Options

0.40, 0.55 and 0.85 mL

Viscosity

300,000 cps

Composition

1.0% sodium hyaluronate

Molecular Weight

4,000,000 Da

REFERENCES

  1. HEALON OVD [package insert]. Santa Ana, Calif. Abbott Medical Optics Inc.
  2. Hutz WW, Ekhardt B, Kohnen T. Comparison of viscoelastic substances used in phacoemulsification. J Cataract Refract Surg. 1996;22:955-959.

INDICATIONS AND IMPORTANT SAFETY INFORMATION FOR THE HEALON® OPHTHALMIC VISCOELASTIC DEVICE

CAUTION

Federal law restricts this device to sale, distribution and use by or on the order of a physician.

INDICATIONS

The HEALON® OVD is indicated for use as a surgical aid in cataract extraction (intra- and extracapsular), IOL implantation, corneal transplant, glaucoma filtration and retinal attachment surgery. In surgical procedures in the anterior segment of the eye, instillation of the HEALON® OVD serves to maintain a deep anterior chamber during surgery, allowing for efficient manipulation with less trauma to the corneal endothelium and other surrounding tissues. Furthermore, its viscoelasticity helps to push back the vitreous face and prevent formation of a postoperative flat chamber. In posterior segment surgery the HEALON® OVD serves as a surgical aid to gently separate, maneuver and hold tissues. The HEALON® OVD creates a clear field of vision thereby facilitating intra- and post-operative inspection of the retina and photocoagulation.

CONTRAINDICATIONS

At present there are no known contraindications to the use of the HEALON® OVD when used as recommended.

PRECAUTIONS

Those normally associated with the surgical procedure being performed. Overfilling the anterior or posterior segment of the eye with the HEALON® OVD may cause increased intraocular pressure, glaucoma, or other ocular damage. Postoperative intraocular pressure may also be elevated as a result of pre-existing glaucoma, compromised outflow and by operative procedures and sequelae thereto, including enzymatic zonulysis, absence of an iridectomy, trauma to filtration structures, and by blood and lenticular remnants in the anterior chamber. Since the exact role of these factors is difficult to predict in any individual case, the following precautions are recommended: Don't overfill the eye chambers with the HEALON® OVD (except in glaucoma surgery). In posterior segment procedures in aphakic diabetic patients special care should be exercised to avoid using large amounts of the HEALON® OVD. Remove some of the HEALON® OVD by irrigation and/or aspiration at the close of surgery (except in glaucoma surgery). Carefully monitor the intraocular pressure, especially during the immediate postoperative period. If significant rises are observed, treat with appropriate therapy. Care should be taken to avoid trapping air bubbles behind the HEALON® OVD. Because the HEALON® OVD is a highly purified fraction extracted from avian tissues and is known to contain minute amounts of protein, the physician should be aware of potential risks of the type that can occur with the injection of any biological material. Because of reports of an occasional release of minute rubber particles, presumably formed when the diaphragm is punctured, the physician should be aware of this potential problem. Express a small amount of the HEALON® OVD from the syringe prior to use, and carefully examine the remainder as it is injected. Reprocessed cannulas should not be used. Sporadic reports have been received indicating that the HEALON® OVD may become ”cloudy” or form a slight precipitate following instillation into the eye. The clinical significance of these reports, if any, is not known since the majority received to date do not indicate any harmful effects on ocular tissues. The physician should be aware of this phenomenon and, should it be observed, remove the cloudy or precipitated material by irrigation and/or aspiration. In vitro laboratory studies suggest that this phenomenon may be related to interactions with certain concomitantly administered ophthalmic medications. Use only if solution is clear.

ADVERSE EVENTS

The HEALON® OVD is extremely well tolerated after injection into human eyes. A transient rise of intraocular pressure postoperatively has been reported in some cases. In posterior segment surgery intraocular pressure rises have been reported in some patients, especially in aphakic diabetics, after injection of large amounts of the HEALON® OVD. Rarely, postoperative inflammatory reactions (iritis, hypopyon) as well as incidents of corneal edema and corneal decompensation have been reported. Their relationship to the HEALON® OVD has not been established.

ATTENTION

Reference the Directions for Use for a complete listing of indications, warnings, and precautions.

PP2017MLT0317

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. All other trademarks are the intellectual property of their respective owners.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?

true
accessibility
© 2017 Abbott Laboratories Inc. Abbott Park, Illinois, USA. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. All other trademarks are the intellectual property of their respective owners.

accessibility

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. All other trademarks are the intellectual property of their respective owners.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?